+39 02 610346.1 - info@newron.com

Investors and Media

Investors and Media

Newron Pharmaceuticals is headquartered in Bresso, Italy and its shares are listed on SIX Swiss Exchange under the ticker symbol NWRN. Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, including our latest share price, key financial data and presentations and webcasts.

 

Newron news see all

Shareholders accepted all motions at the AGM 2018

 

Newron announces 2017 financial results and provides outlook for 2018

 

Newron Supports Global Rare Disease Day® 2018 and Rett Syndrome Studies

 

Change in the Board of Directors

 

Primary endpoint met in phase II/III clinical study of investigational Parkinson’s disease treatment safinamide in Japan

Stock information

Download centre

Email alerts

 

 

 

 

 

Upcoming Eventssee all

UBS Global Healthcare Conference

May 21 – 23, 2018 - Grand Hyatt New York, NY, US

Bio€quity Europe 2018

May 14-16, 2018 - Ghent, Belgium

Swiss Biotech Day 2018

May 3, 2018 -  Congress Center Basel, Switzerland